Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Businesswire News Releases

Apr 25, 2024 07:30 ET
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th....
Apr 25, 2024 07:30 ET
Country Launches Future of Nursing Study Unveiling the Balance of AI Integration and Preserving Humanity in Healthcare
Today, Cross Country Healthcare, Inc. (NASDAQ: CCRN), a pioneering force in tech-driven workforce solutions and advisory services, in collaboration with the Florida Atlantic University's Christine E. Lynn College of Nursing, released its latest research findings in the fourth annual installment of the Future of Nursing survey: "Embracing Technology While Preserving Humanity." Drawing insights from over 1,100 nursing professionals and students, the study illuminates the intricate interplay between cutting-edge healthcare technologies and the enduring essence of compassionate care....
Apr 25, 2024 07:30 ET
Cybin to Participate at the 27th Annual Milken Institute Global Conference
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced that Doug Drysdale, Cybin’s Chief Executive Officer, will be speaking at the 27...
Apr 25, 2024 07:30 ET
EMCOR Group, Inc. Reports First Quarter 2024 Results
EMCOR Group, Inc. (NYSE: EME) today reported results for the first quarter ended March 31, 2024....
Apr 25, 2024 07:30 ET
Lincoln Electric Reports First Quarter 2024 Results
Lincoln Electric Holdings, Inc. (the “Company”) (Nasdaq: LECO) today reported first quarter 2024 net income of $123.4 million, or diluted earnings per share (EPS) of $2.14, which includes special item after-tax net charges of $5.2 million, or $0.09 EPS. This compares with prior year period net income of $121.9 million, or $2.09 EPS, which included special item after-tax net charges of $2.3 million, or $0.04 EPS. Excluding special items, first quarter 2024 adjusted net income was $128.7 million, or $2.23 adjusted EPS. This compares with adjusted net income of $124.2 million, or $2.13 adjusted E...
Apr 25, 2024 07:15 ET
The Spaceport Company Signs Agreement with Maritime Launch to Provide Tracking and Telemetry Stations for Spaceport Nova Scotia
Maritime Launch Services Inc. (Cboe: MAXQ, OTCB: MAXQF) and The Spaceport Company have inked a Letter of Intent (LOI) to lease a containerized tracking and telemetry station (TTS) from The Spaceport Company (TSC) for an inaugural orbital launch from Canada, with options to purchase multiple units as Maritime Launch operations ramp up....
Apr 25, 2024 07:00 ET
Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Rese
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the treatment of retinitis pigmentosa....
Apr 25, 2024 07:00 ET
Comcast Reports 1st Quarter 2024 Results
Comcast Corporation (NASDAQ: CMCSA) today reported results for the quarter ended March 31, 2024....
Apr 25, 2024 07:00 ET
Expro Group Holdings N.V. Announces First Quarter 2024 Results
Expro Group Holdings N.V. (NYSE: XPRO) (the “Company” or “Expro”) today reported financial and operational results for the three months ended March 31, 2024....
Apr 25, 2024 07:00 ET
Flygreen Recognized as a Top 10 Innovator at the 2024 Canadian Business Innovation Awards
Flygreen™, a Momentum Ventures subsidiary that offers customized private jet experiences with a commitment to sustainability and environmental responsibility, is proud to announce that it has been named as a top 10 innovator at the 2024 Canadian Business I...
Apr 25, 2024 07:00 ET
GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET....
Apr 25, 2024 07:00 ET
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will hos...
Apr 25, 2024 07:00 ET
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income From Operations
Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce its financial and operating results for the fourth quarter and fiscal year ended December 31, 2023. All figures are reported in Canadian dollars ($), unless otherwise indicated. Indiva's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS"). For a more comprehensive overview of the corporate and financial highlights presented in this news release, please refer to Indiva's Management's Discus...
Apr 25, 2024 07:00 ET
Intevac Announces First Quarter 2024 Financial Results
Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the first quarter ended March 30, 2024....
Apr 25, 2024 07:00 ET
Laser Photonics’ Laser Technology Meets Unique Cleaning Needs of Precision Optics Manufacturers
Laser Photonics Corporation (LPC), a leading global developer of industrial laser systems for laser cleaning and other material processing applications, highlights a key application for its
Apr 25, 2024 07:00 ET
LiveWire Group, Inc. Reports 2024 First Quarter Financial Results
LiveWire Group, Inc. (“LiveWire” or the “Company”) (NYSE: LVWR) today reported first quarter 2024 results....
Apr 25, 2024 07:00 ET
Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it published an article in the Experimental and Therapeutic Medicine Journal, titled “Long-term complete response to namodenoson in liver cancer with Child-Pugh B cirrhosis: A case report” (
Apr 25, 2024 07:00 ET
MindMed to Present at Upcoming May Medical Conferences
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study of MM120 in Generalized Anxiety Disorder (GAD), as well as multiple presentations describing the epidemiology and growing burden of GAD at two upcoming medical conferences:...
Apr 25, 2024 07:00 ET
Mission Bio's New Translocation Analysis Offers Insights into Critical Safety Assessment for Gene-Edited Cell Products
Mission Bio, a leader in single-cell multiomic solutions for precision medicine, today announced the launch of a new single-cell capability that enhances our understanding of translocations (chromosomal rearrangements) in gene-edited therapies. Measuring predicted translocations along with on- and off-target editing at single-cell resolution can enable dev...